Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study

Duloxetine

(2011) Mary Pat Knadler et al.   CLINICAL PHARMACOKINETICS

The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans

(2011) C M Hysek et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Sex Differences in the Effects of MDMA (Ecstasy) on Plasma Copeptin in Healthy Subjects

(2011) Linda D. Simmler et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

High concentrations of MDMA (‘ecstasy’) and its metabolite MDA inhibit calcium influx and depolarization-evoked vesicular dopamine release in PC12 cells

(2011) Laura Hondebrink et al.   NEUROPHARMACOLOGY

Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter

(2011) Brent J. Thompson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others

(2010) Gillinder Bedi et al.   BIOLOGICAL PSYCHIATRY

Transmembrane Domain 6 of the Human Serotonin Transporter Contributes to an Aqueously Accessible Binding Pocket for Serotonin and the Psychostimulant 3,4-Methylene Dioxymethamphetamine

(2010) Julie R. Field et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Rab11 Supports Amphetamine-Stimulated Norepinephrine Transporter Trafficking

(2010) H. J. G. Matthies et al.   JOURNAL OF NEUROSCIENCE

Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)

(2010) Erich Studerus et al.   PLoS One

Evidence for noncompetitive modulation of substrate-induced serotonin release

(2010) Richard B. Rothman et al.   SYNAPSE

Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose study

(2009) Rui-ke Zhao et al.   CLINICAL THERAPEUTICS

Physiological and Subjective Responses to Controlled Oral 3,4-Methylenedioxymethamphetamine Administration

(2009) Erin A. Kolbrich et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A Closer Look at Amphetamine-Induced Reverse Transport and Trafficking of the Dopamine and Norepinephrine Transporters

(2009) S. D. Robertson et al.   MOLECULAR NEUROBIOLOGY

Atomoxetine Attenuates Dextroamphetamine Effects in Humans

(2009) Mehmet Sofuoglu et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor

(2008) Christopher D Verrico et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain

(2008) Michael H. Baumann et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR